472 related articles for article (PubMed ID: 26188316)
1. Systemic delivery of micelles loading with paclitaxel using N-succinyl-palmitoyl-chitosan decorated with cRGDyK peptide to inhibit non-small-cell lung cancer.
Yuan ZQ; Li JZ; Liu Y; Chen WL; Yang SD; Zhang CG; Zhu WJ; Zhou XF; Liu C; Zhang XN
Int J Pharm; 2015 Aug; 492(1-2):141-51. PubMed ID: 26188316
[TBL] [Abstract][Full Text] [Related]
2. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
3. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
[TBL] [Abstract][Full Text] [Related]
4. Cyclic RGDyK conjugation facilitates intracellular drug delivery of polymeric micelles to integrin-overexpressing tumor cells and neovasculature.
Yin J; Li Z; Yang T; Wang J; Zhang X; Zhang Q
J Drug Target; 2011 Jan; 19(1):25-36. PubMed ID: 20233083
[TBL] [Abstract][Full Text] [Related]
5. Encapsulation of paclitaxel into lauric acid-O-carboxymethyl chitosan-transferrin micelles for hydrophobic drug delivery and site-specific targeted delivery.
Nam JP; Park SC; Kim TH; Jang JY; Choi C; Jang MK; Nah JW
Int J Pharm; 2013 Nov; 457(1):124-35. PubMed ID: 24076228
[TBL] [Abstract][Full Text] [Related]
6. Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy.
Jiang C; Wang H; Zhang X; Sun Z; Wang F; Cheng J; Xie H; Yu B; Zhou L
Int J Pharm; 2014 Nov; 475(1-2):60-8. PubMed ID: 25152167
[TBL] [Abstract][Full Text] [Related]
7. [pH-sensitive micelles loaded paclitaxel using carboxymethyl chitosan-palmitic acid mediated by cRGD].
Li JZ; Yuan ZQ; Yan M; Li MW; Zhang XN
Yao Xue Xue Bao; 2016 Apr; 51(4):642-9. PubMed ID: 29860751
[TBL] [Abstract][Full Text] [Related]
8. Enhanced antitumor efficacy by paclitaxel-loaded pluronic P123/F127 mixed micelles against non-small cell lung cancer based on passive tumor targeting and modulation of drug resistance.
Zhang W; Shi Y; Chen Y; Yu S; Hao J; Luo J; Sha X; Fang X
Eur J Pharm Biopharm; 2010 Aug; 75(3):341-53. PubMed ID: 20451605
[TBL] [Abstract][Full Text] [Related]
9. Thermosensitive micelles-hydrogel hybrid system based on poloxamer 407 for localized delivery of paclitaxel.
Ju C; Sun J; Zi P; Jin X; Zhang C
J Pharm Sci; 2013 Aug; 102(8):2707-17. PubMed ID: 23839931
[TBL] [Abstract][Full Text] [Related]
10. [Preparation of paclitaxel-loaded chitosan polymeric micelles and influence of surface charges on their tissue biodistribution in mice].
Huo MR; Zhou JP; Wei Y; Lü L
Yao Xue Xue Bao; 2006 Sep; 41(9):867-72. PubMed ID: 17111835
[TBL] [Abstract][Full Text] [Related]
11. In vivo evaluation of novel chitosan graft polymeric micelles for delivery of paclitaxel.
Liu J; Li H; Chen D; Jin X; Zhao X; Zhang C; Ping Q
Drug Deliv; 2011 Apr; 18(3):181-9. PubMed ID: 20942638
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel.
Zhang C; Qu G; Sun Y; Wu X; Yao Z; Guo Q; Ding Q; Yuan S; Shen Z; Ping Q; Zhou H
Biomaterials; 2008 Mar; 29(9):1233-41. PubMed ID: 18093646
[TBL] [Abstract][Full Text] [Related]
13. Novel amphiphilic folic acid-cholesterol-chitosan micelles for paclitaxel delivery.
Cheng LC; Jiang Y; Xie Y; Qiu LL; Yang Q; Lu HY
Oncotarget; 2017 Jan; 8(2):3315-3326. PubMed ID: 27926514
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel-loaded N-octyl-O-sulfate chitosan micelles for superior cancer therapeutic efficacy and overcoming drug resistance.
Jin X; Mo R; Ding Y; Zheng W; Zhang C
Mol Pharm; 2014 Jan; 11(1):145-57. PubMed ID: 24261922
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
16. Enhanced antitumor efficacy by cyclic RGDyK-conjugated and paclitaxel-loaded pH-responsive polymeric micelles.
Gao Y; Zhou Y; Zhao L; Zhang C; Li Y; Li J; Li X; Liu Y
Acta Biomater; 2015 Sep; 23():127-135. PubMed ID: 26013038
[TBL] [Abstract][Full Text] [Related]
17. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration.
Lv PP; Wei W; Yue H; Yang TY; Wang LY; Ma GH
Biomacromolecules; 2011 Dec; 12(12):4230-9. PubMed ID: 22044456
[TBL] [Abstract][Full Text] [Related]
18. Amphiphilic N-(2,3-dihydroxypropyl)-chitosan-cholic acid micelles for paclitaxel delivery.
Pan Z; Gao Y; Heng L; Liu Y; Yao G; Wang Y; Liu Y
Carbohydr Polym; 2013 Apr; 94(1):394-9. PubMed ID: 23544554
[TBL] [Abstract][Full Text] [Related]
19. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
[TBL] [Abstract][Full Text] [Related]
20. PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery.
Chu B; Qu Y; Huang Y; Zhang L; Chen X; Long C; He Y; Ou C; Qian Z
Int J Pharm; 2016 Mar; 500(1-2):345-59. PubMed ID: 26794876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
